Through analysis of long-term data, we demonstrated that genotypes of IL28B and PNPLA3 are independent predictors of rapid fibrosis progression in patients with chronic hepatitis C who failed to achieve SVR following interferon-based therapy. This evidence concerns the gene PNPLA3 and chronic hepatitis C virus infection.